Stocks of SI-BONE Inc (NASDAQ:SIBN) traded higher last session on Wall Street, down -2.74% to $16.68.
SIBN stock price is now -0.14% away from the 50-day moving average and 9.29% away from the 200-day moving average. The market capitalization of the company currently stands at $710.81M.
With the price target reduced from $27 to $19, Needham maintained Buy rating for SI-BONE Inc (NASDAQ: SIBN). On March 28, 2024, Piper Sandler recently initiated its ‘Overweight’ rating on the stock quoting a target price of $25, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, DUNN JEFFREY W, Director sold 3,377 shares of the company’s stock on Jun 05 ’25. The stock was sold for $64,335 at an average price of $19.05. Upon completion of the transaction, the Director now directly owns 17,354 shares in the company, valued at $0.29 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 16 ’25, Chief Executive Officer FRANCIS LAURA sold 12,385 shares of the business’s stock. A total of $243,670 was realized by selling the stock at an average price of $19.67. This leaves the insider owning 495,170 shares of the company worth $8.26 million. A total of 13.46% of the company’s stock is owned by insiders.
During the past 12 months, SI-BONE Inc has had a low of $11.70 and a high of $20.05. As of last week, the company has a debt-to-equity ratio of 0.22, a current ratio of 8.53, and a quick ratio of 7.26. The fifty day moving average price for SIBN is $16.704 and a two-hundred day moving average price translates $15.2628 for the stock.
The latest earnings results from SI-BONE Inc (NASDAQ: SIBN) was released for 2025-03-31. The net profit margin was -15.04% and return on equity was -15.96% for SIBN. The company reported revenue of $47.29 million for the quarter, compared to $37.87 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 24.88 percent.
